Phase III Study of Surufatinib in Treating Advanced Pancreatic Neuroendocrine Tumors

Clinical trial NCT02589821 · COMPLETED

Trial details

NCT number: NCT02589821
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuroendocrine Tumors

Start date: 2015-12-07
Primary completion: 2019-11-11
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.